Nothing Special   »   [go: up one dir, main page]

AR026784A1 - Dihidrobenzopiranos sustituidos y analogos de los mismos para el tratamiento de afecciones mediadas por cox-2. - Google Patents

Dihidrobenzopiranos sustituidos y analogos de los mismos para el tratamiento de afecciones mediadas por cox-2.

Info

Publication number
AR026784A1
AR026784A1 ARP010100018A ARP010100018A AR026784A1 AR 026784 A1 AR026784 A1 AR 026784A1 AR P010100018 A ARP010100018 A AR P010100018A AR P010100018 A ARP010100018 A AR P010100018A AR 026784 A1 AR026784 A1 AR 026784A1
Authority
AR
Argentina
Prior art keywords
treatment
mediated
dihydrobenzopiranos
affections
cox
Prior art date
Application number
ARP010100018A
Other languages
English (en)
Original Assignee
Pharmacia Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22635573&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR026784(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pharmacia Corp filed Critical Pharmacia Corp
Publication of AR026784A1 publication Critical patent/AR026784A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
    • C07D335/04—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D335/06—Benzothiopyrans; Hydrogenated benzothiopyrans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Quinoline Compounds (AREA)
  • Pyrane Compounds (AREA)

Abstract

Se describe una clase de dihidrobenzopiranos, dihidrobenzotiopiranos, tetrahidroquinolinas, tetrahidronaftalenos y análogos de los mismos para su uso en eltratamiento de las afecciones mediadas por la ciclooxigenasa-2. Los compuestos de interés parti cular se definen en la formula 1 donde X, A1, A2, A3, A4, R, R11, R1 y R2 son como se describe en la memoria descriptiva.
ARP010100018A 2000-01-03 2001-01-03 Dihidrobenzopiranos sustituidos y analogos de los mismos para el tratamiento de afecciones mediadas por cox-2. AR026784A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US17428100P 2000-01-03 2000-01-03

Publications (1)

Publication Number Publication Date
AR026784A1 true AR026784A1 (es) 2003-02-26

Family

ID=22635573

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP010100018A AR026784A1 (es) 2000-01-03 2001-01-03 Dihidrobenzopiranos sustituidos y analogos de los mismos para el tratamiento de afecciones mediadas por cox-2.

Country Status (16)

Country Link
US (2) US6822102B2 (es)
EP (1) EP1274700B1 (es)
JP (1) JP2003519221A (es)
AR (1) AR026784A1 (es)
AT (1) ATE282604T1 (es)
AU (1) AU2584001A (es)
CA (1) CA2395795A1 (es)
DE (1) DE60016047T2 (es)
EC (1) ECSP013867A (es)
ES (1) ES2231301T3 (es)
MX (1) MXPA02006617A (es)
PE (1) PE20010995A1 (es)
PT (1) PT1274700E (es)
TW (1) TWI227234B (es)
WO (1) WO2001049675A1 (es)
ZA (1) ZA200205098B (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030100594A1 (en) * 2001-08-10 2003-05-29 Pharmacia Corporation Carbonic anhydrase inhibitor
US7504508B2 (en) 2002-10-04 2009-03-17 Millennium Pharmaceuticals, Inc. PGD2 receptor antagonists for the treatment of inflammatory diseases
PL376156A1 (en) 2002-10-04 2005-12-27 Millennium Pharmaceuticals, Inc. Pgd2 receptor antagonists for the treatment of inflammatory diseases
CA2424009A1 (en) 2003-03-28 2004-09-28 Ibm Canada Limited - Ibm Canada Limitee Context-sensitive attributes
GB0407908D0 (en) * 2004-04-07 2004-05-12 Univ York Ionic liquids
TW200603792A (en) * 2004-04-23 2006-02-01 Pharmacia & Upjohn Co Llc Monotherapy for the treatment of psoriasis with cyclooxygenase-2 selective inhibitors
US7122700B2 (en) 2004-07-30 2006-10-17 Xerox Corporation Arylamine processes
WO2006040672A1 (en) * 2004-10-12 2006-04-20 Pharmacia & Upjohn Company Llc Substituted cyclopropyl chromene compounds for use in the treatment and prevention of inflammation related conditions
KR20070114762A (ko) 2005-02-24 2007-12-04 밀레니엄 파머슈티컬스 인코퍼레이티드 염증 질환 치료를 위한 ｐｇｄ2 수용체 길항제
US7999107B2 (en) 2007-01-31 2011-08-16 Merck Sharp & Dohme Corp. Substituted pyrano[2,3-B]pyridine derivatives as cannabinoid-1 receptor modulators
PE20130404A1 (es) 2010-07-14 2013-04-17 Novartis Ag Compuestos heterociclicos agonistas del receptor ip
TW201335160A (zh) 2012-01-13 2013-09-01 Novartis Ag Ｉｐ受體激動劑之雜環化合物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1234029A (zh) * 1996-08-27 1999-11-03 盐野义制药株式会社 色烯－3－羚酸衍生物
DE19638484A1 (de) * 1996-09-20 1998-03-26 Basf Ag Hetaroylderivate
US6077850A (en) * 1997-04-21 2000-06-20 G.D. Searle & Co. Substituted benzopyran analogs for the treatment of inflammation
US6034256A (en) * 1997-04-21 2000-03-07 G.D. Searle & Co. Substituted benzopyran derivatives for the treatment of inflammation

Also Published As

Publication number Publication date
DE60016047T2 (de) 2005-11-03
WO2001049675A1 (en) 2001-07-12
TWI227234B (en) 2005-02-01
ZA200205098B (en) 2004-03-31
ATE282604T1 (de) 2004-12-15
ES2231301T3 (es) 2005-05-16
AU2584001A (en) 2001-07-16
PE20010995A1 (es) 2001-09-21
EP1274700A1 (en) 2003-01-15
EP1274700B1 (en) 2004-11-17
MXPA02006617A (es) 2004-09-10
PT1274700E (pt) 2005-02-28
CA2395795A1 (en) 2001-07-12
US20050010050A1 (en) 2005-01-13
DE60016047D1 (de) 2004-12-23
ECSP013867A (es) 2002-09-27
JP2003519221A (ja) 2003-06-17
US6822102B2 (en) 2004-11-23
US20030232844A1 (en) 2003-12-18

Similar Documents

Publication Publication Date Title
AR026784A1 (es) Dihidrobenzopiranos sustituidos y analogos de los mismos para el tratamiento de afecciones mediadas por cox-2.
ECSP066467A (es) Formas Polimórficas de 3-(4-amino-1-Oxo-1-3 DIhidroisoindol-2-IL)-Piperidin-2,6-Diona
AR024839A1 (es) Compuesto bi o triciclico sustituido, su uso en la fabricacion de un medicamento y composicion farmaceutica que lo comprende.
TR200100410T2 (tr) 2-(purin-9-il)-tetrahidrofuran-3,4-diol türevleri.
ECSP066539A (es) Derivados 1-amino-2-oxi sustituidos del tetrahidronaftaleno, procedimiento para su preparación y su uso como antiinflamatorio
PT1305301E (pt) Benzeno-acetamidas alfa-acilo e alfa-heteroatomo-substituidas activadoras da glucocinase
CO5310550A1 (es) Nuevo derivado de androstano antiinflamatorio, su polimorfo, sus formas cristalinas solvatadas, composiciones farmaceutias, proceso para prepararlo, intermediario
DOP2002000433A (es) 2-tio-3,5-diciano-4-fenil-6-aminopiridinas substituidas y su uso
ECSP056063A (es) 6-alquil o alquenil-4-aminopicolinatos y uso de los mismos como herbicidas
UY27571A1 (es) 2-tio-3, 5-diciano-4-fenil-6-aminopiridinas sustituidas y su uso
ECSP055980A (es) Oxazolidinonas de indolona y derivados de las mismas
SV2004001549A (es) Difenilazetidinonas sustituidas en anillo, procedimiento para su preparacion, medicamentos que comprenden estos compuestos y su uso
ECSP077306A (es) Derivados de alquiliden-tetrahidronaftaleno, procedimiento para su preparación y su uso como antiinflamatorios
ECSP034531A (es) Derivados sustituidos de c-ciclohexilmetilamina
PA8589801A1 (es) Aminoalcoxiindoles
AR028743A1 (es) DERIVADOS DE N-TRIAZOLILMETIL-PIPERAZINA CON ACCIoN ANTAGONISTA DE RECEPTORES DE NEUROQUININA
ECSP034532A (es) Derivados del 1-aminobutan-3-ol sustituido
UY29481A1 (es) Derivados de tetrahidronaftalina, procedimientos para su preparación y su uso como antiinflamatorios.
DE60017374D1 (de) Antibakterielle mittel
BRPI0414873A (pt) derivados de imidazopiridina como inibidores de no-sintase induzìveis
UY26568A1 (es) Nuevos derivados de amidas heterocíclicas
ATE399169T1 (de) Imidazopyridinderivate als inhibitoren der induzierbaren no-synthase
ATE398617T1 (de) Imidazoä4,5-büpyridinderivate als inhibitoren der induzierbaren no-synthase
UY28145A1 (es) Nuevos compuestos farmaceuticos
BR0110959A (pt) Derivados de 7-nitro-2,1,3-benzoxadiazol e 7-nitro-2,1,3-benzotiadiazol, bem como agentes de tingimento para fibras de queratina que contêm esses compostos

Legal Events

Date Code Title Description
FA Abandonment or withdrawal